Nonsteroidal anti-inflammatory drugs' adverse drug reactions: 10 years of national database data by G. I. Syraeva, A. S. Kolbin

Connect to this object online.

COMPARATIVE REVIEW OF METHODOLOGIES FOR ESTIMATING THE COST OF ADVERSE DRUG REACTIONS IN THE RUSSIAN FEDERATION AND BRAZIL by G. I. Syraeva, A. S. Kolbin, A. V. Matveev, V. S. Panezhina

Connect to this object online.

Quantitative and qualitative evaluation of the use of nonsteroidal anti-inflammatory drugs in the Russian Federation over 10 years by G. I. Syraeva, A. S. Kolbin, S. A. Mishinova, A. A. Kalyapin

Connect to this object online.

Optimisation of Approaches to Adverse Event Analysis in Bioequivalence Clinical Trials by A. B. Verveda, V. B. Vasilyuk, G. I. Syraeva, M. V. Faraponova

Connect to this object online.

Assessment of the influence of demographic and anthropometric indicators on the variability of pharmacokinetic parameters by V. B. Vasilyuk, A. B. Verveda, M. V. Faraponova, G. I. Syraeva

Connect to this object online.

Toxic reactions of non-steroidal anti-inflammatory drugs in the Russian Federation, analysis of the national database "Pharmacovigilance" by G. I. Syraeva, V. B. Vasilyuk, A. V. Verveda, M. V. Faraponova, A. S. Kolbin, V. G. Borovskaya

Connect to this object online.

Comparative evaluation of safety parameters at the preclinical and clinical stages of the study of the Reamberin® (LLC "POLYSAN") by V. B.  Vasilyuk, M. V. Faraponova, G. I. Syraeva, A. B. Verveda, A. V. Belskaya, A.  V. Shults, L. G. Kubarskaya, E. A. Zolotoverkhaya

Connect to this object online.

Individual features of the pharmacokinetics of fludarabin phosphate in the treatment of patients with chronic lymphocytic leukemia by G. G. Rodionov, I. I. Shantyr, V. B. Vasilyuk, E. A. Kolobova, E. V. Svetkina, M. V. Faraponova, A. B. Verveda, G. I. Syraeva, K. A. Zakharov

Connect to this object online.